Académique Documents
Professionnel Documents
Culture Documents
Where the terms and conditions of options are modified before they vest, the increase in the fair value of the options,
measured immediately before and after the modification, is also charged to the statement of comprehensive loss/income over
the remaining vesting period.
All equity-settled share-based payments are reflected in share-based payment reserve, until exercised. Upon exercise,
shares are issued from treasury and the amount reflected in share-based payment reserve is credited to share capital,
adjusted for any consideration paid. The fair value of share-based compensation awards are calculated using the Black-
Scholes option pricing model ("Black-Scholes"). Option pricing models require the input of highly subjective assumptions,
including the expected price volatility. Changes in these assumptions can materially affect the fair value estimate.
Where a grant of options is cancelled or settled during the vesting period, excluding forfeitures when vesting conditions are
not satisfied, the Company immediately accounts for the cancellation as an acceleration of vesting and recognizes the
amount that otherwise would have been recognized for services received over the remainder of the vesting period. Any
payment made to the employee on the cancellation is accounted for as the repurchase of an equity interest except to the
extent the payment exceeds the fair value of the equity instrument granted, measured at the repurchase date. Any such
excess is recognized as an expense.
Certain pronouncements were issued by the IASB or the IFRS Interpretations Committee that are mandatory for accounting
years beginning on or after January 1, 2013 or later years. The following standards and interpretations have been issued but
are not yet effective:
Where equity-settled share options are awarded to employees, the fair value of the options at the date of grant is charged to
the statement of comprehensive loss/income over the vesting period. Performance vesting conditions are taken into account
by adjusting the number of equity instruments expected to vest at each reporting date so that, ultimately, the cumulative
amount recognized over the vesting period is based on the number of options that eventually vest. Non-vesting conditions
and market vesting conditions are factored into the fair value of the options granted. As long as all other vesting conditions
are satisfied, a charge is made irrespective of whether these vesting conditions are satisfied. The cumulative expense is not
adjusted for failure to achieve a market vesting condition or where a non-vesting condition is not satisfied.
IFRS 10 builds on existing principles by identifying the concept of control as the determining factor in whether an entity
should be included within the consolidated financial statements of the parent company. The standard provides additional
guidance to assist in the determination of control where this is difficult to assess. The Company intends to adopt this
standard no later than the accounting period beginning on July 1, 2013. The adoption of this standard will not have a
significant impact on the Companys financial statements.
IAS 1 - Presentation of Financial Statements
In June 2011, the IASB and the Financial Accounting Standards Board (FASB) issued amendments to standards to align
the presentation requirements for other comprehensive income (OCI). The IASB issued amendments to IAS - Presentation
of Financial Statements to require companies preparing financial statements under IFRS to group items within OCI that
may be reclassified to the profit or loss. The amendments also reaffirm existing requirements that items in OCI and profit
or loss should be presented as either a single statement or two consecutive statements. The amendments to IAS 1 set out
in Presentation of Items of Other Comprehensive Income will be implemented beginning on July 1, 2013. The adoption of
this standard will not have a significant impact on the Companys financial statements.
IFRS 9 Financial Instruments
IFRS 9 Financial Instruments is part of the IASB's wider project to replace IAS 39 Financial Instruments: Recognition and
Measurement. IFRS 9 retains but simplifies the mixed measurement model and establishes two primary measurement
categories for financial assets: amortized cost and fair value. The basis of classification depends on the entity's business
model and the contractual cash flow characteristics of the financial asset. The standard is effective for annual periods
beginning on or after January 1, 2015.
IFRS 10 Consolidated Financial Statements
NioCorp Developments Ltd.
(formerly Quantum Rare Earth Developments Corp.)
Notes to Consolidated Financial Statements
June 30, 2013
(in Canadian dollars)
3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES continued